DEF: Doximity Schedules 2026 Annual Meeting and Seeks Director Re-elections

Doximity, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for August 27, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Summary

• Doximity, Inc. is holding its virtual Annual Meeting of Stockholders for fiscal year 2026 on August 27, 2026.
• The meeting will cover the election of two Class II directors, ratification of Deloitte & Touche LLP as the independent auditor for the year ending March 31, 2027, and an advisory vote on executive compensation.
• Stockholders of record as of July 2, 2026, are entitled to vote.
• Voting can be done online, by telephone, or by mail until August 26, 2026, or during the virtual meeting.
• The company's board of directors recommends voting FOR the director nominees, FOR the auditor ratification, and FOR the executive compensation proposal.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily concerns routine annual meeting matters, though the significant legal settlements and ongoing litigation introduce a negative element.

Positives

• The company is holding its annual meeting to ensure continued corporate governance and stockholder engagement.
• The board recommends approval of all proposals, indicating confidence in current management and strategic direction.
• The virtual meeting format aims to provide ease of access and cost savings for stockholders.
• A strong majority of stockholders supported the executive compensation program in the previous year's advisory vote (96.5%).

Negatives

• The company is facing multiple lawsuits, including a securities class action lawsuit that has been settled for $31 million, and ongoing derivative lawsuits.
• A separate lawsuit alleges unauthorized access to a platform, with counterclaims filed by Doximity.

Risks

• Ongoing derivative lawsuits against certain directors and officers, with outcomes currently unpredictable.
• The lawsuit filed by OpenEvidence Inc. alleging unauthorized access to its platform is proceeding, with potential for unfavorable outcomes or settlement costs.
• Potential for future litigation or regulatory scrutiny related to user data, AI, and platform security.

Future Outlook

The filing does not contain specific forward-looking financial guidance but focuses on the upcoming annual meeting agenda and corporate governance matters.

Management Comments

• Jeff Tangney, CEO, expresses gratitude for stockholder support and invites participation in the Annual Meeting.
• The Board of Directors recommends voting FOR the director nominees, auditor ratification, and executive compensation proposal.

Industry Context

StockSavvy.ai notes that Doximity's annual meeting proxy statement is a standard procedural filing, but the ongoing litigation and the company's focus on AI in healthcare are key areas to monitor for future strategic and financial implications.

Comparison to Industry Standards

• Doximity's peer group for executive compensation decisions includes companies like AppFolio, Guidewire Software, Asana, HashiCorp, Bill.com, HealthEquity, C3.ai, Klaviyo, Certara, nCino, Clearwater Analytics, PagerDuty, Confluent, Phreesia, DigitalOcean, Procore Technologies, Dynatrace, Samsara, Elasticsearch, Smartsheet, GoodRx, and SPS Commerce.
• The company's executive compensation philosophy aligns with industry best practices, emphasizing long-term incentives and performance-based awards.
• The company's audit committee operates under a charter that satisfies SEC and NYSE listing standards, a common practice for publicly traded companies.

Corporate Governance

Legal Proceedings

• Securities lawsuit settled for $31 million, subject to court approval, with final approval granted on June 23, 2026.
• Seven shareholder derivative lawsuits are ongoing, asserting claims against directors and officers.
• Lawsuit filed by OpenEvidence Inc. alleging unauthorized access to its AI platform, with counterclaims filed by Doximity; litigation is proceeding.
• A demand on the board to investigate was made by shareholder Constance McCrea and agreed to be held in abeyance pending resolution of the securities lawsuit.

Related Party Transactions

• Dr. Regina Benjamin, a director, entered into a consulting agreement to provide strategic advisory services for the PeerCheck initiative, with compensation in RSUs valued at approximately $2,000,000.

Stakeholder Impact

• Shareholders: Voting rights on director elections, auditor ratification, and executive compensation; potential impact from legal settlements and ongoing litigation.
• Management and Employees: Continued focus on performance-based compensation and retention incentives; potential impact from legal outcomes.
• Auditors: Ratification of Deloitte & Touche LLP's appointment for the upcoming fiscal year.

Next Steps

• Stockholders to vote on the proposed resolutions by August 26, 2026, or during the Annual Meeting.
• The company will file a Form 8-K with preliminary voting results within four business days after the Annual Meeting.

Key Dates

Recommendation

The filing is primarily procedural, related to the annual meeting. While the company's core business and market position remain strong, the significant legal settlements and ongoing litigation introduce considerable uncertainty and risk, warranting a cautious 'hold' stance until these matters are fully resolved and their financial impact is clearer.

Keywords

Doximity, Annual Meeting, Proxy Statement, Director Election, Executive Compensation, Auditor Ratification, Stockholder Vote, Corporate Governance